Enforcement Report - Week of March 30, 2022
Enforcement Report- Week of June 30, 2021
Teligent Pharma’s Generic Diflorasone Diacetate Receives Approval In US
Riconpharma’s Generic Diflorasone Diacetate Receives Approval In US